No Data
No Data
Express News | Accelerate Diagnostics - Received Written Notice From Nasdaq Notifying Co That It Had Regained Compliance With Minimum Bid Price Requirement
Accelerate Diagnostics Unveils Executive Incentive Plan Linked to FDA Goals
12 Health Care Stocks Moving In Thursday's After-Market Session
GainersOneMedNet (NASDAQ:ONMD) stock moved upwards by 15.6% to $1.7 during Thursday's after-market session. The company's market cap stands at $40.5 million. 23andMe Holding (NASDAQ:ME) shares increas
12 Health Care Stocks Moving In Tuesday's Intraday Session
GainersBiodexa Pharmaceuticals (NASDAQ:BDRX) stock increased by 84.3% to $2.34 during Tuesday's regular session. The market value of their outstanding shares is at $10.2 million. Genelux (NASDAQ:GNLX)
Accelerate Diagnostics' Shareholder Decisions at Annual Meeting
Accelerate Diagnostics | 10-Q: Quarterly report
No Data
RiotMaraMan : Was wondering why MULN price is o high since I last bought it a year ago.
Now realised MULN not in good shape and will probably dissappear in 2025 together with Lucid and Fisker.
Am not touching MULN for sure.